CRE pathogens a priority

The health care market is failing to support new antibiotics accustomed treat a number of the world’s most dangerous, drug-resistant “superbugs,” per a brand-new analysis by University of Pittsburgh faculty of drugs communic...

New study determines the ‘chilling’ future of antibiotics

Based on a new study conducted by a team of infectious disease scientists of University of Pittsburgh School of Medicine, the healthcare market was not conducive for new antibiotics targeting some of the most dangerous and drug-resistant “superbugs”.

Based on the study, the ...